WCG Blog
Insights from the WIRB-Copernicus Group
-
Read PostThere is Value to Patients When Independent Sites Offer Clinical Trials
-
Read PostCOVID-19 Changed Everything: Now Contracts and Budgets Need to Catch Up
- 2020 Prospectus
-
Read PostFour Tips For Navigating Patient Recruitment During COVID-19
-
Read PostWCG: Advocating for Patients in a time of COVID-19
-
Read PostCOVID-19 Insights from Former FDA Commissioner, Scott Gottlieb, MD
The coronavirus has spread beyond the point of containment, and there’s a looming shortage of personal protective equipment. Hear insights from former FDA Commissioner, Scott Gottlieb, MD.
-
Read PostCOVID-19 Preparedness for Health Care Institutions with Dr. Paul Biddinger of Massachusetts General Hospital
-
Read PostEssential Considerations for CTMS Integrations and Data Migrations
-
Read PostNIH Launches NExTRAC to Advise on Emerging Biotechnologies
-
Read PostBe the Site of Choice
In early October, over hundreds of representatives of clinical research sites and members from biopharmaceutical companies came together for WCG’s Global Research Network™ Be the Site of Choice Event.
-
Read PostAn Overview of the Recent SACHRP Recommendations Around Payments in Clinical Research
-
Read PostWhat if Patients and Patient Advocates Spoke About Clinical Trial Participation and the Key Issues that Affected Trial Participation?
A forum to gather Patient Advocacy Groups, their constituents, and key stakeholders in drug development to advance and insist upon meaningful change in clinical research.
-
Read PostIn the Gut, In the Environment, On the iPad: Emerging Developments in Autism Research
We are, at last, beginning to better understand the broad range of phenotypic differences in what we classify as autism spectrum disorders.
-
Read PostLessons Learned from 600+ Expert Committee Members
We asked our network of over 600 experts to share with us what they think makes an expert committee successful.
-
Read PostYour 5 Questions About Enrollment Assistants Answered
-
Read PostWhat You Don’t Know About Patient Recruitment Can Impede the Success of Your Trial
-
Read PostGet under the hood while the trial is running: Identify and rectify data problems before it's too late
How can sponsors maximize assay and endpoint sensitivity? And are you meeting scientific and regulatory expectations for quality data in clinical trials?
-
Read PostDe-risking Clinical Trials Through Analytic Supported, On-Demand Medical Expertise From The World’s Leading Clinical Trial Experts
-
Read Post4 Tips to Bolster Your Regulatory Strategy
-
Read PostTo Mitigate Placebo Response, Test, Train and Control Expectations
The placebo effect: it’s the curse of clinical trials across indications. Luckily, training patients to accurately report their symptoms has been proven to reduce placebo response.
-
Read PostAmendments to the NIH Guidelines: Effects on Human Gene Transfer Research
On April 25th, NIH Director Francis Collins announced the release of the amended NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. The most important take-home...
-
Loading More...
